Join the Campaign

Influenza vaccines on target, but only half effective

With at least 5 weeks left in season, CDC medical officer says patients who have not been vaccinated yet should get vaccinated

If it seems like you’ve been seeing an uptick in patients who are ill with influenza despite being vaccinated, it’s not your imagination. This season’s Northern Hemisphere vaccines are on target, yet only offer 48% protection against medically attended influenza, according to CDC officials in a February 16 Community Outreach and Communication Activity conference call and webinar.

Among samples U.S. laboratories sent to CDC since October 1, 100% of the influenza A (H1N1)pdm09 viruses and B/Yamagata-lineage viruses, 96.6% of the A(H3N2), and 90.9% of the B/Victoria lineage viruses were antigenically similar to components of the 2016–17 vaccines. Yet estimates for medically attended influenza midway through the season suggest the vaccines’ effectiveness to be just 43% for A(H3N2), the season’s most widely circulating virus. Effectiveness is estimated to be 73% for influenza B viruses.

The vaccines’ mediocre effectiveness is not surprising, according to Angela Campbell, MD, MPH, FAAP, FPIDS, FIDSA, medical officer in the Influenza Division’s Epidemiology and Prevention Branch at the National Center for Immunization and Respiratory Diseases. “Even when there is a good match, these vaccines are less effective against H3 [viruses].”

That shouldn’t be a deterrent to getting vaccinated, Campbell added. “Influenza vaccines are effective at reducing the risk of a person getting the flu and having to go to the doctor by about half. We still have [at least] 5 weeks to go this season, so patients who have not been vaccinated yet should get vaccinated.”

Estimates from the National Immunization Survey—Flu, Behavioral Risk Factor Surveillance System, and National Internet Flu Survey suggest that 37.3% of children and 40.6% of adults have been vaccinated against influenza this season thus far.

As could be expected, those older than 65 years have had the highest rate of influenza-related hospitalizations at roughly 115 per 100,000 people. Yet this season has a twist, said Alicia Budd, MPH, an epidemiologist in the Influenza Division’s Epidemiology and Prevention Branch at the National Center for Immunization and Respiratory Diseases. “What is unusual is that the 50–64 [years] age range have had more hospitalizations than the 0–4 [years] age group. The older group were hit harder early in the season.”

As of February 10, there were 25 hospitalizations per 100,000 people in the 50–64 years age group, compared to 15 hospitalizations per 100,000 people in the 0–4 years age group.

The ratios may change, said Budd. “Now the younger age group is picking up [in hospitalizations], so we we’ll have to wait until the end of the season to see if the two groups converge.”

Budd noted that influenza activity in the United States began to rise early last December, remained high through mid-January, and is expected to continue for several more weeks. For the week ending February 4, 2017, 23 states reported high rates of influenza-like illness (ILI) activity, and 10 states reported moderate ILI activity.  

Ad Position: 
Bottom Center Aligned
  • Join the Campaign
  • Take Action ALT Text
  • Get the facts ALT text
LATEST NEWS
October 17, 2017
October 17, 2017
APhA Executive Vice President and CEO Thomas E. Menighan, BSPharm, MBA, ScD (Hon), FAPhA, testified in a hearing about drug prices held by the...
Gag clauses, lack of provider status hinder cost-effective care, importation is no solution, APhA CEO says
MORE
August 14, 2017
August 14, 2017
Tennessee saw major provider status legislation take effect on July 1. “Pharmacists as Providers” (HB 405/SB 461) gives Tennessee pharmacists formal...
‘Pharmacists as providers’ legislation went into effect July 1
MORE
July 13, 2017
July 13, 2017
The Massachusetts Senate and House of Representatives health care committee held a hearing on legislation that would expand the scope of practice...
Hearing held last month included testimony from pharmacists and physicians
MORE
Advertisement